Mangalam Drugs and Organics Ltd posts lower PAT of Rs. 3 crore in Q1 FY2023

Mangalam Drugs And Organics Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 109.5015 crores during the period ended June 30, 2022 as compared to Rs. 120.9555 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 3.0038 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 6.6915 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 1.92 for the period ended June 30, 2022 as compared to Rs. 4.23 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 109.5015 crs	₹120.9555 crs	-9.47%
Net Profit	₹3.0038 crs	₹6.6915 crs	-55.11%
EPS	₹1.92	₹4.23	-54.61%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 109.5015 crores during the period ended June 30, 2022 as compared to Rs.105.3007 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.3.0038 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.4.4158 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.1.92 for the period ended June 30, 2022 as compared to Rs.2.79 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 109.5015 crs	₹105.3007 crs	3.99%
Net Profit	₹3.0038 crs	₹4.4158 crs	-31.98%
EPS	₹1.92	₹2.79	-31.18%

Shares of Mangalam Drugs And Organics Limited was last trading in BSE at Rs. 144.25 as compared to the previous close of Rs. 143.45. The total number of shares traded during the day was 4877 in over 242 trades.

The stock hit an intraday high of Rs. 146.90 and intraday low of 142.45. The net turnover during the day was Rs. 706973.00.

Source : Equity Bulls

Keywords

MangalamDrugsandOrganics Q1FY23 ResultUpdate